Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Immunogen

    Client Virtual Booth

    IMMUNOGEN

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Immunogen
    Immunogen
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    830 Winter Street Waltham, MA 02451-1477
    Telephone
    Telephone
    781-895-0600
    Client Email
    Email
    info@immunogen.com
    Client Website
    Website
    https://www.immunogen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/immunogen-inc.
    Twitter
    Twitter
    Contact Info
    Others

    Full View ScreenFull Screen View
    In less than 3 months, AbbVie closes $10.1B buyout of ImmunoGen
    In less than 3 months, AbbVie closes $10.1B buyout of ImmunoGen

    https://www.fiercepharma.com/pharma/abbvie-quickly-wraps-its-101b-buyout-immunogen-another-good-sign-biopharma-ma

    FIERCE PHARMA
    12 Feb 2024
    Share Share
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.businesswire.com/news/home/20240201135762/en

    BUSINESSWIRE
    01 Feb 2024
    Share Share
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.businesswire.com/news/home/20240102637834/en

    BUSINESSWIRE
    03 Jan 2024
    Share Share
    Filing reveals how AbbVie's $10B ImmunoGen offer won out
    Filing reveals how AbbVie's $10B ImmunoGen offer won out

    https://www.fiercepharma.com/pharma/inside-abbvies-10b-immunogen-buyout-and-bidding-war-it-won

    Zoey Becker FIERCE PHARMA
    02 Jan 2024
    Share Share
    ImmunoGen Presents Findings from Phase 1b/2 Study of Pivekimab Sunirine at ASH
    ImmunoGen Presents Findings from Phase 1b/2 Study of Pivekimab Sunirine at ASH

    https://www.businesswire.com/news/home/20231210537316/en

    BUSINESSWIRE
    10 Dec 2023
    Share Share
    FDA Grants Priority Review of ImmunoGen’s Supplemental BLA for ELAHERE
    FDA Grants Priority Review of ImmunoGen’s Supplemental BLA for ELAHERE

    https://www.businesswire.com/news/home/20231205658270/en

    BUSINESSWIRE
    05 Dec 2023
    Share Share
    AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio
    AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio

    https://www.reuters.com/markets/deals/abbvie-buy-immunogen-101-billion-boost-cancer-drug-portfolio-2023-11-30/

    REUTERS
    01 Dec 2023
    Share Share
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.businesswire.com/news/home/20231201600597/en

    BUSINESSWIRE
    01 Dec 2023
    Share Share
    ImmunoGen Announces Webcast of Presentation
    ImmunoGen Announces Webcast of Presentation

    https://www.businesswire.com/news/home/20231102139307/en

    BUSINESSWIRE
    02 Nov 2023
    Share Share
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.businesswire.com/news/home/20231101753557/en

    BUSINESSWIRE
    01 Nov 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Immunogen

    Iran Expo

    Not Confirmed

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search